Global Endoscopic Retrograde Cholangiopancreatography Market Size & Outlook
Global endoscopic retrograde cholangiopancreatography market, 2018-2030 (US$M)
Related Markets
Global endoscopic retrograde cholangiopancreatography market highlights
- The global endoscopic retrograde cholangiopancreatography market generated a revenue of USD 2,169.1 million in 2024 and is expected to reach USD 3,507.6 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 8.3% by 2030.
- In terms of segment, endotherapy devices accounted for a revenue of USD 873.0 million in 2024.
- Endoscopes is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 2,169.1 million |
| Market revenue in 2030 | USD 3,507.6 million |
| Growth rate | 8.3% (CAGR from 2025 to 2030) |
| Largest segment | Endotherapy devices |
| Fastest growing segment | Endoscopes |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices |
Other key industry trends
- In terms of revenue, the North America accounted for 50.0% of the global endoscopic retrograde cholangiopancreatography market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 56.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endoscopic Retrograde Cholangiopancreatography Market Scope
Endoscopic Retrograde Cholangiopancreatography Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ambu A/S Class B | View profile | 4750 | Baltorpbakken 13, Ballerup, Denmark, DK-2750 | http://www.ambu.com |
| Cook Group | View profile | 10001+ | Bloomington, Indiana, United States, North America | http://www.cookgroup.com |
| Karl Storz | View profile | 1001-5000 | Tuttlingen, Baden-Wurttemberg, Germany, Europe | https://www.karlstorz.com/ |
| Telemed Systems | View profile | 11-50 | Hudson, Massachusetts, United States, North America | https://telemedsystems.com |
| Hobbs Medical | View profile | 11-50 | Stafford Springs, Connecticut, United States, North America | https://www.hobbsmedical.com |
| Conmed Corp | View profile | 4000 | 11311 Concept Boulevard, Largo, FL, United States, 33773 | https://www.conmed.com |
| Hoya Corp | View profile | 36571 | 20th Floor Nishi-Shinjuku Building, 6-10-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan, 160-8347 | http://www.hoya.co.jp |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Olympus Corp | View profile | 33629 | Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan, 163-0914 | http://www.olympus.co.jp |
| Steris PLC | View profile | 17100 | 5960 Heisley Road, Mentor, OH, United States, 44060 | https://www.steris-ir.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
Global endoscopic retrograde cholangiopancreatography market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endoscopic retrograde cholangiopancreatography market will help companies and investors design strategic landscapes.
Endotherapy devices was the largest segment with a revenue share of 40.25% in 2024. Horizon Databook has segmented the Global endoscopic retrograde cholangiopancreatography market based on endoscopes, endotherapy devices, visualization systems, energy devices covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Endoscopic Retrograde Cholangiopancreatography Product Outlook (Revenue, USD Million, 2018-2030)
- Endoscopes
- Endotherapy Devices
- Sphincterotomes
- Lithotripter
- Stents
- Cannulas
- Forceps
- Snares
- Catheters
- Guiding Wires
- Balloons
- Baskets
- Visualization Systems
- Energy Devices
- Others
- Global Endoscopic Retrograde Cholangiopancreatography Procedure Outlook (Revenue, USD Million, 2018-2030)
- Biliary Sphincterotomy
- Biliary Stenting
- Biliary Dilatation
- Pancreatic Sphincterotomy
- Pancreatic Duct Stenting
- Pancreatic Duct Dilation
- Global Endoscopic Retrograde Cholangiopancreatography End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Outpatient Facilities
Reasons to subscribe to Global endoscopic retrograde cholangiopancreatography market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global endoscopic retrograde cholangiopancreatography market databook
-
Our clientele includes a mix of endoscopic retrograde cholangiopancreatography market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global endoscopic retrograde cholangiopancreatography market , including forecasts for subscribers. This global databook contains high-level insights into Global endoscopic retrograde cholangiopancreatography market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global endoscopic retrograde cholangiopancreatography market size, by regions, 2018-2030 (US$M)
Top 10 countries: Endoscopic retrograde cholangiopancreatography market size, 2024 (US$M)
Global endoscopic retrograde cholangiopancreatography market share, by product, 2024 & 2030 (%, US$M)
Endoscopic retrograde cholangiopancreatography market: Opportunity assessment by country
Global endoscopic retrograde cholangiopancreatography market, by region, 2024 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
